Cannapharmarx Stock Price Prediction
| CPMD Stock | USD 0 0.0002 4.76% |
Momentum 53
Impartial
Oversold | Overbought |
Using CannaPharmaRx hype-based prediction, you can estimate the value of CannaPharmaRx from the perspective of CannaPharmaRx response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in CannaPharmaRx to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying CannaPharmaRx because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
CannaPharmaRx after-hype prediction price | USD 0.002726 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
CannaPharmaRx |
CannaPharmaRx After-Hype Price Density Analysis
As far as predicting the price of CannaPharmaRx at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in CannaPharmaRx or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of CannaPharmaRx, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
CannaPharmaRx Estimiated After-Hype Price Volatility
In the context of predicting CannaPharmaRx's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on CannaPharmaRx's historical news coverage. CannaPharmaRx's after-hype downside and upside margins for the prediction period are 0.00 and 24.70, respectively. We have considered CannaPharmaRx's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
CannaPharmaRx is out of control at this time. Analysis and calculation of next after-hype price of CannaPharmaRx is based on 3 months time horizon.
CannaPharmaRx Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as CannaPharmaRx is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CannaPharmaRx backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with CannaPharmaRx, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.14 | 24.70 | 0.00 | 0.00 | 0 Events / Month | 1 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0 | 0 | 31.85 |
|
CannaPharmaRx Hype Timeline
CannaPharmaRx is currently traded for 0. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. CannaPharmaRx is expected to decline in value after the next headline, with the price expected to drop to 0.002726. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -31.85%, whereas the daily expected return is currently at 2.14%. The volatility of related hype on CannaPharmaRx is about 1.646666667E7%, with the expected price after the next announcement by competition of 0.00. The company recorded a loss per share of 0.12. CannaPharmaRx had not issued any dividends in recent years. The entity had 1:10 split on the 10th of November 2006. Given the investment horizon of 90 days the next expected press release will be in 5 to 10 days. Check out CannaPharmaRx Basic Forecasting Models to cross-verify your projections.CannaPharmaRx Related Hype Analysis
Having access to credible news sources related to CannaPharmaRx's direct competition is more important than ever and may enhance your ability to predict CannaPharmaRx's future price movements. Getting to know how CannaPharmaRx's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how CannaPharmaRx may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CBDY | Target Group | (0) | 2 per month | 14.38 | 0.07 | 35.71 | (28.57) | 100.00 | |
| ALID | Allied Corp | 0.00 | 1 per month | 0.00 | (0.13) | 0.00 | 0.00 | 95.50 | |
| PLSH | Panacea Life Sciences | 0.00 | 0 per month | 9.59 | 0.02 | 28.00 | (27.55) | 94.50 | |
| MJARF | MJardin Group | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXMT | Anything Tech Media | 0.00 | 0 per month | 11.86 | 0.09 | 33.33 | (25.00) | 133.33 | |
| CNNA | Cann American Corp | 0.00 | 0 per month | 19.63 | 0.17 | 66.67 | (40.00) | 2,040 | |
| SRUTF | Sproutly Canada | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LVVEF | Yooma Wellness | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MSTH | Mystic Holdings | 0.00 | 1 per month | 0.00 | 0.11 | 0.00 | 0.00 | 721.39 | |
| APPB | Applied Biosciences Corp | 0.00 | 6 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CannaPharmaRx Additional Predictive Modules
Most predictive techniques to examine CannaPharmaRx price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for CannaPharmaRx using various technical indicators. When you analyze CannaPharmaRx charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About CannaPharmaRx Predictive Indicators
The successful prediction of CannaPharmaRx stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as CannaPharmaRx, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of CannaPharmaRx based on analysis of CannaPharmaRx hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to CannaPharmaRx's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to CannaPharmaRx's related companies.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Complementary Tools for CannaPharmaRx Pink Sheet analysis
When running CannaPharmaRx's price analysis, check to measure CannaPharmaRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CannaPharmaRx is operating at the current time. Most of CannaPharmaRx's value examination focuses on studying past and present price action to predict the probability of CannaPharmaRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CannaPharmaRx's price. Additionally, you may evaluate how the addition of CannaPharmaRx to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |